Back
Results - Announcements
Sales rise 41.41% to Rs 77.38 crore
Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter
05-Nov-2024, 04:37
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023.
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 77.38 | 54.72 | 41 |
| OPM % | 13.69 | 19.66 | - |
| PBDT | 6.03 | 10.67 | -43 |
| PBT | 5.56 | 10.01 | -44 |
| NP | 4.59 | 14.43 | -68 |
Powered by Capital Market - Live News